Skip to main content
Clinical Trials/JPRN-UMIN000038067
JPRN-UMIN000038067
Not yet recruiting
未知

A study to evaluate the effects of foods containing indigestible dextrin on the blood glucose elevation inhibitory effect Rondomised,double blind, placebo controlled crossover study - A study to evaluate the effects of foods containing indigestible dextrin on the blood glucose elevation inhibitory effect Rondomised,double blind, placebo controlled crossover study

Miura Clinic, Medical Corporation Kanonkai0 sites10 target enrollmentSeptember 20, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
healthy individuals
Sponsor
Miura Clinic, Medical Corporation Kanonkai
Enrollment
10
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 20, 2019
End Date
December 31, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Miura Clinic, Medical Corporation Kanonkai

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Subjects with a history of diabetes, liver disease, kidney disease, gastrointestinal disease, peripheral vascular disorder, and other serious diseases (2\) Subjects who may have allergic symptoms due to ingredients in the test food (3\) Subjects with impaired cardiopulmonary function (4\) Subjects with abnormal liver and kidney function test values (5\) Subjects who have undergone gastrointestinal surgery (6\) Subjects with a disease currently being treated (7\) Subjects with food and drug allergies (8\) Subjects who have a habit of smoking (9\) Subjects who play intense sports and are on a diet (10\) Subjects taking food, health foods, quasi\-drugs, and pharmaceuticals (including OTC and prescription drugs) that may affect the endpoints of the study (11\) Subjects who are excessively consuming alcohol or subjects who cannot ban alcohol from 2 days before the test date (12\) Subjects who are pregnant or who are scheduled to become pregnant or breastfeeding during the study period (13\) Subjects who are or will be participating in other clinical studies at the start of this study (14\) Other subjects deemed inappropriate by the investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials